Back to Search
Start Over
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
- Source :
- ENP Newswire. October 2, 2024
- Publication Year :
- 2024
-
Abstract
- ENPNewswire-October 2, 2024--Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 01102024 - RAHWAY - Merck (NYSE: MRK), known as MSD [...]
- Subjects :
- Merck & Company Inc.
Merck Research Laboratories
Pharmaceutical industry
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- ENP Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.810849325